InvestSMART

Medibio Limited (ASX: MEB) - Announcements

- Current share price for MEB : $0.001

ASX company news and announcements for Medibio Limited (MEB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medibio Limited (MEB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medibio Limited (MEB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medibio Limited (MEB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Quarterly Activities Report 31 Oct 2016 6:09PM $0.460 $0.001 fallen by 99.78%
$6 Quarterly Cashflow Report 31 Oct 2016 6:04PM $0.460 $0.001 fallen by 99.78%
$6 Medibio newsletter to Shareholders 28 Oct 2016 5:02PM $0.460 $0.001 fallen by 99.78%
$6 Notice of Annual General Meeting/Proxy Form 28 Oct 2016 4:43PM $0.460 $0.001 fallen by 99.78%
$6 Appendix 3B 28 Oct 2016 4:35PM $0.460 $0.001 fallen by 99.78%
$6 Receipt of $3,074,224 R & D Tax Incentive Refund 14 Oct 2016 10:38AM $0.490 $0.001 fallen by 99.80%
$6 Partners with HBF and Vital Conversations on mental health 11 Oct 2016 10:34AM $0.500 $0.001 fallen by 99.80%
$6 Funding Update 10 Oct 2016 9:37AM $0.490 $0.001 fallen by 99.80%
$6 Appendix 3B 7 Oct 2016 7:37PM $0.490 $0.001 fallen by 99.80%
$6 Annual Report to shareholders 30 Sep 2016 1:40PM $0.415 $0.001 fallen by 99.76%
$6 Appendix 4G - Corporate Governance Disclosure 30 Sep 2016 1:34PM $0.415 $0.001 fallen by 99.76%
$6 Final Director's Interest Notice 30 Sep 2016 1:24PM $0.415 $0.001 fallen by 99.76%
$6 Director Resignation 30 Sep 2016 1:22PM $0.415 $0.001 fallen by 99.76%
$6 Medibio and Monash Groundbreaking partnership on innovation 14 Sep 2016 10:13AM $0.390 $0.001 fallen by 99.74%
$6 Appendix 3B 6 Sep 2016 10:11AM $0.380 $0.001 fallen by 99.74%
$6 Preliminary Final Report 31 Aug 2016 5:17PM $0.360 $0.001 fallen by 99.72%
$6 Medibio Investor Presentation 23 Aug 2016 12:05AM $0.335 $0.001 fallen by 99.70%
$6 Commercial Trial and Validation Update 17 Aug 2016 12:37AM $0.350 $0.001 fallen by 99.71%
$6 Breakthrough validation of depression test with Ottawa Univ 8 Aug 2016 1:39PM $0.325 $0.001 fallen by 99.69%
$6 Trading Halt 5 Aug 2016 9:40AM $0.325 $0.001 fallen by 99.69%
$6 Appendix 4C - quarterly 1 Aug 2016 8:20AM $0.320 $0.001 fallen by 99.69%
$6 Appendix 3B 30 Jun 2016 5:13PM $0.325 $0.001 fallen by 99.69%
$6 Copy of Presentation to be given to US Investors over the ne 28 Jun 2016 10:03AM $0.300 $0.001 fallen by 99.67%
$6 MEB Advanced Analytics Cloud Solution breaks new ground in S 24 Jun 2016 10:13AM $0.310 $0.001 fallen by 99.68%
$6 Medibio's first commercial pilot study a success 30 May 2016 9:56AM $0.250 $0.001 fallen by 99.60%

526 - 550 of 620 results

Page 22 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.